Estimation of the force of infection and infectious period of skin sores in remote Australian communities using interval-censored data

Prevalence of impetigo (skin sores) remains high in remote Australian Aboriginal communities, Fiji, and other areas of socio-economic disadvantage. Skin sore infections, driven primarily in these settings by Group A Streptococcus (GAS) contribute substantially to the disease burden in these areas. Despite this, estimates for the force of infection, infectious period and basic reproductive ratio — all necessary for the construction of dynamic transmission models — have not been obtained. By utilising three datasets each containing longitudinal infection information on individuals, we estimate each of these epidemiologically important parameters. With an eye to future study design, we also quantify the optimal sampling intervals for obtaining information about these parameters. We verify the estimation method through a simulation estimation study, and test each dataset to ensure suitability to the estimation method. We find that the force of infection differs by population prevalence, and the infectious period is estimated to be between 12 and 20 days. We also find that optimal sampling interval depends on setting, with an optimal sampling interval between 9 and 11 days in a high prevalence setting, and 21 and 27 days for a lower prevalence setting. These estimates unlock future model-based investigations on the transmission dynamics of GAS and skin sores.

[1]  N. Geard,et al.  Implications of asymptomatic carriers for infectious disease transmission and control , 2018, Royal Society Open Science.

[2]  Nigel G. Bean,et al.  An induced natural selection heuristic for finding optimal Bayesian experimental designs , 2017, Comput. Stat. Data Anal..

[3]  Jodie McVernon,et al.  Characterising pandemic severity and transmissibility from data collected during first few hundred studies. , 2017, Epidemics.

[4]  Dwight R. Johnson,et al.  Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci , 2017, Journal of the Pediatric Infectious Diseases Society.

[5]  R. Moss,et al.  Model selection for seasonal influenza forecasting , 2017, Infectious Disease Modelling.

[6]  James M. McCaw,et al.  Forecasting influenza outbreak dynamics in Melbourne from Internet search query surveillance data , 2016, Influenza and other respiratory viruses.

[7]  R. Speare,et al.  Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community , 2015, PLoS neglected tropical diseases.

[8]  R. Hay,et al.  The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma , 2015, PloS one.

[9]  J. Kaldor,et al.  Prevalence of scabies and impetigo worldwide: a systematic review. , 2015, The Lancet. Infectious diseases.

[10]  J. Kaldor,et al.  Scabies and Impetigo Prevalence and Risk Factors in Fiji: A National Survey , 2015, PLoS neglected tropical diseases.

[11]  Robert L. Wolpert,et al.  Statistical Inference , 2019, Encyclopedia of Social Network Analysis and Mining.

[12]  M. Chatfield,et al.  The microbiology of impetigo in Indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus,scabies, and nasal carriage , 2014, BMC Infectious Diseases.

[13]  M. Chatfield,et al.  Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial , 2014, The Lancet.

[14]  A. McEwan,et al.  An antimicrobial role for zinc in innate immune defense against group A streptococcus. , 2014, The Journal of infectious diseases.

[15]  E. Nsoesie,et al.  A systematic review of studies on forecasting the dynamics of influenza outbreaks , 2013, Influenza and other respiratory viruses.

[16]  J. Carapetis,et al.  Clinic Attendances during the First 12 Months of Life for Aboriginal Children in Five Remote Communities of Northern Australia , 2013, PloS one.

[17]  P. Suñé,et al.  Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results , 2013, PloS one.

[18]  R. Gautam,et al.  Salmonella Fecal Shedding and Immune Responses are Dose- and Serotype- Dependent in Pigs , 2012, PloS one.

[19]  J. Carapetis,et al.  Skin disease in the first two years of life in Aboriginal children in East Arnhem Land , 2011, The Australasian journal of dermatology.

[20]  V. Nizet,et al.  Molecular insight into invasive group A streptococcal disease , 2011, Nature Reviews Microbiology.

[21]  Christopher H. Jackson,et al.  Multi-State Models for Panel Data: The msm Package for R , 2011 .

[22]  P. Pollett,et al.  Locally optimal designs for the simple death process , 2010 .

[23]  Eric A. Suess,et al.  Introduction to Probability Simulation and Gibbs Sampling with R , 2010 .

[24]  J. Carapetis,et al.  A Regional Initiative to Reduce Skin Infections amongst Aboriginal Children Living in Remote Communities of the Northern Territory, Australia , 2009, PLoS neglected tropical diseases.

[25]  J. Bouyer,et al.  The Population Structure of Glossina palpalis gambiensis from Island and Continental Locations in Coastal Guinea , 2009, PLoS neglected tropical diseases.

[26]  N. Grassly,et al.  The Natural History of Trachoma Infection and Disease in a Gambian Cohort with Frequent Follow-Up , 2008, PLoS neglected tropical diseases.

[27]  J. Carapetis,et al.  Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia. , 2008, Bulletin of the World Health Organization.

[28]  M. Keeling,et al.  Modeling Infectious Diseases in Humans and Animals , 2007 .

[29]  M. McDonald,et al.  Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  G. Bensi,et al.  Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome , 2006, Nature Biotechnology.

[31]  J. McArthur,et al.  Is plasminogen deployed as a Streptococcus pyogenes virulence factor? , 2005, Trends in microbiology.

[32]  G. Roberts,et al.  Bayesian inference for partially observed stochastic epidemics , 1999 .

[33]  J. Carapetis,et al.  Success of a scabies control program in an Australian aboriginal community. , 1997, The Pediatric infectious disease journal.

[34]  J Grüger,et al.  The validity of inferences based on incomplete observations in disease state models. , 1991, Biometrics.

[35]  I M Longini,et al.  Statistical inference for infectious diseases. Risk-specific household and community transmission parameters. , 1988, American journal of epidemiology.

[36]  Forbes Jc,et al.  Early onset Campylobacter sepsis in a neonate. , 1987 .

[37]  H. Dillon,et al.  The natural history of streptococcal skin infection: prevention with topical antibiotics. , 1985, Journal of the American Academy of Dermatology.

[38]  E. Walter,et al.  Robust experiment design via stochastic approximation , 1985 .

[39]  A. Dajani,et al.  Natural history of impetigo. II. Etiologic agents and bacterial interactions. , 1972, The Journal of clinical investigation.

[40]  A. Dajani,et al.  Natural history of impetigo. I. Site sequence of acquisition and familial patterns of spread of cutaneous streptococci. , 1972, The Journal of clinical investigation.

[41]  L. Wannamaker,et al.  The role of normal skin in the spread of streptococcal pyoderma , 1970, Journal of Hygiene.

[42]  R Fisher,et al.  Design of Experiments , 1936 .

[43]  W. O. Kermack,et al.  A contribution to the mathematical theory of epidemics , 1927 .